Business context and reporting period
Nova Measuring Instruments Ltd. filed this Form 20-F annual report for the fiscal year ended December 31, 2020. It is not a standalone Q4 report; the filing does not provide clear quarterly financial results. Nova develops and sells optical and X-ray metrology systems and software for semiconductor manufacturing. Financial statements are prepared under U.S. GAAP and audited by Kost Forer Gabbay & Kasierer, which issued unqualified opinions on the financial statements and internal controls.
Key financial metrics
| Metric | 2020 | 2019 | Change |
|---|---|---|---|
| Revenue | $269.4 million | $224.9 million | +19.8% |
| Gross profit / margin | $152.9 million / 56.8% | $121.8 million / 54.2% | Margin +2.6 percentage points |
| Operating income / margin | $55.6 million / 20.6% | $36.4 million / 16.2% | Operating income +52.6% |
| Net income / diluted EPS | $47.9 million / $1.65 | $35.2 million / $1.23 | Net income +36.2% |
| Operating cash flow | $60.3 million | $40.7 million | +$19.6 million |
| Cash, cash equivalents and bank deposits | $427.9 million | $189.1 million | Increased mainly from operating cash and note proceeds |
| Working capital | $497.8 million | $256.7 million | +$241.1 million |
| Total assets / shareholders’ equity | $655.8 million / $371.5 million | $400.4 million / $314.5 million |
Products generated $209.3 million of revenue, up 25.2%; services generated $60.1 million, up 4.1%. Product gross margin improved to 62.5% from 59.7%, while service gross margin declined to 36.9% from 38.0%. R&D expense was $53.0 million, sales and marketing $29.3 million, and G&A $12.5 million. Net financing income fell to $0.9 million from $3.1 million, including $2.2 million of net foreign-exchange losses and $0.9 million of convertible-note expense. Income tax expense was $8.6 million, or a 15.2% effective rate.
Capital expenditures were $6.4 million. Operating cash flow less capital expenditures was approximately $53.8 million. The company issued $200 million principal amount of 0% convertible senior notes due October 2025; the year-end net carrying value was $178.8 million. The notes are senior unsecured obligations, with an initial conversion price of approximately $74.60 per share. Management reported approximately $249.1 million of cash reserves net of the notes’ long-term carrying value.
Material changes versus the prior comparable period
- Revenue rebounded after falling 10.4% in 2019; 2020 growth reflected higher demand across main product lines, including new products.
- Gross and operating margins recovered from 2019, supported by higher sales and product mix. Net income remained below 2018’s $54.4 million.
- Operating cash flow rose to $60.3 million from $40.7 million. Inventories increased to $61.7 million from $48.4 million, attributed to new products, service inventory and full-capacity manufacturing during COVID-19.
- Cash and deposits increased substantially following the October note offering. Long-term debt was newly recorded, alongside $13.8 million of equity component from the convertible-note accounting.
- The five largest customers contributed 72% of revenue, up from 67% in 2019; two customers accounted for 26% and 24%, respectively, in 2020.
Outlook, commentary, risks and unusual items
Management’s 2021 priorities include product and technology development, expanding applications in advanced logic and memory, growing software-algorithm sales, and deepening customer partnerships. It expects 2021 capital spending of approximately $10 million and plans higher aggregate operating expenses than in 2020. The filing gives no numerical revenue or earnings guidance. Management stated that current cash reserves should fund planned activities for at least twelve months.
Management cited COVID-19 as a risk to delivery, supply-chain resilience, customer demand and execution, while reporting that it had implemented business-continuity measures. Semiconductor equipment demand is cyclical; lengthy sales cycles, concentrated customers, limited suppliers and single manufacturing facilities per product line add volatility and operational exposure. Other material risks include export restrictions affecting certain Chinese customers, U.S.-China trade measures, Israel-related geopolitical and currency risks, and possible intellectual-property, tax and product-liability exposure. The U.S. dollar weakened 7.0% against the shekel in 2020; the company uses foreign-exchange forwards and options to hedge some exposures.
During the first half of 2020, a fraudster induced a financial institution used by Nova to wire company funds without authorization. G&A included a $3 million expense related to the incident; almost all funds were retrieved, but recovery was not stated to be complete. Nova repurchased $10 million of shares in October 2020 in connection with the note offering. It also had $41.0 million of non-cancelable purchase obligations, primarily due within one year. No significant legal proceedings were reported. The company does not expect to pay cash dividends for the foreseeable future.
Important facts for investors to verify
- Review the complete convertible-note terms, including conversion, repurchase and maturity provisions, dilution potential, and the effect of future accounting-standard changes on reported EPS and working capital.
- Assess customer concentration and geographic exposure: Taiwan represented 33% of revenue, the United States 23%, China 19% and Korea 17%.
- Track inventory growth and reserve adequacy; inventory write-downs were $5.7 million in 2020, compared with $4.4 million in 2019.
- Confirm the final recovery and any residual loss from the unauthorized wire transfers, and consider the adequacy of related cybersecurity and payment controls.
- Monitor execution of the product roadmap, the planned $10 million 2021 capital program, expense growth, and the expected 2022 start of operations at the new Rehovot clean room.
- Consider cash concentration: approximately 30% of cash reserves was held with one financial institution at year-end 2020.